Healthcare Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Bristol-Myers Squib (NYSE:BMY), Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

FB Nasdaq FB Facebook

Congress jumped into the health care game (again) by “complaining” that Gilead Sciences, Inc. (NASDAQ:GILD)’s hepatitis drug was priced too high. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 3.92% in last session and finished the day at $73.64. Traded volume was 19.50million shares in the last session and the average volume of the stock remained 13.29million shares. The beta of the stock remained 0.55. Gilead Sciences, Inc. (NASDAQ:GILD) insider ownership is 0.50%.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) is 6.6% higher at $8.10, as traders digest rumors that Jazz Pharmaceuticals plc (NASDAQ:JAZZ) was willing to pay over $20 per share to buy the firm. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) rose 5.71 percent to $8.52 Tuesday on volume of 12.12million shares. The intra-day range of the stock was $8.02 to $8.55. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has a market capitalization of $1.59billion.

Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the first quarter of 2014 on Tuesday, April 29, 2014. During a conference call at 9 a.m. EDT on April 29, company executives will review financial information and will address inquiries from investors and analysts. Bristol-Myers Squibb Co (NYSE:BMY)’s stock on Apr 01, 2014 reported a decrease of -0.15% to the closing price of $51.87. Its fifty two weeks range is $39.18 -$57.49. The total market capitalization recorded $85.95billion. The overall volume in the last trading session was 7.33million shares. In its share capital, BMY has 1.66billion outstanding shares.

Natco Pharma Industries Ltd (ADR) (NYSE:TEVA) shares remain in focus after the US Supreme Court agreed to hear an appeal filed by Teva Pharmaceutical Industries Ltd in a patent fight over a drug for multiple sclerosis. Natco Pharma Industries Ltd (ADR) (NYSE:TEVA) stock declined 14% in trade yesterday. On Tuesday, shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) advanced 0.44% to close the day at $53.07. Company return on investment (ROI) is 4.90% and its monthly performance is recorded as 8.77%. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) quarterly revenue growth is 33.38%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone